Nephro Care India Ltd
NEPHROCARE NSE
Nephro Care India Ltd
Healthcare ServicesNSE: NEPHROCARE Hospitals
Key Fundamentals
SMEHospitalsHealthcare ServicesMarket Cap
₹152 Cr
Volatility
Moderate
P/E Ratio
44.8
EBITDA
₹8.32 Cr
Return on Equity
6.8%
Debt to Equity
0
Book Value
₹34.49
52W High
₹183
52W Low
₹50.05
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Nephro Care India Ltd insights
29 extracted metrics + investor summaries across FY20–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 10.7% over last 3 years.
Growth Rate
Revenue Growth
86.41% ↗
Net Income Growth
-10.83% ↘
Cash Flow Change
759.34% ↗
ROE
-77.31% ↘
ROCE
-78.21% ↘
EBITDA Margin (Avg.)
-40.75% ↘
Quarterly Results
| Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 17.33 | 22.66 | 26.75 | 29.19 |
| Expenses | 16.73 | 20.75 | 24.73 | 25.57 |
| Operating Profit | 0.6 | 1.91 | 2.02 | 3.62 |
| OPM % | 3.46% | 8.43% | 7.55% | 12.4% |
| Other Income | 0.05 | 0.08 | 0.83 | 0.22 |
| Interest | 0.14 | 0.03 | -0.01 | 0.03 |
| Depreciation | 1.16 | 1.4 | 1.56 | 1.19 |
| PBT | -0.65 | 0.56 | 1.3 | 2.62 |
| Tax % | 0% | 25% | 23.08% | 38.17% |
| Net Profit | -0.65 | 0.42 | 1 | 1.61 |
| EPS in Rs | -0.39 | 0.25 | 0.61 | 0.98 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.54 | 1.82 | 3.42 | 17.09 | 27.23 | 46.03 | 88.73 |
| Expenses | 0.52 | 1.67 | 3.28 | 13.66 | 20.76 | 40.16 | 80.41 |
| Operating Profit | 0.02 | 0.15 | 0.14 | 3.43 | 6.47 | 5.87 | 8.32 |
| OPM % | 3.7% | 8.24% | 4.09% | 20.07% | 23.76% | 12.75% | 9.38% |
| Other Income | 0.01 | 0.01 | -0.01 | 0 | 0.28 | 1.53 | 1.55 |
| Interest | 0.04 | 0.03 | 0.02 | 0.07 | 0.09 | 0.11 | 0.16 |
| Depreciation | 0 | 0.01 | 0.11 | 0.78 | 0.53 | 2.46 | 5.07 |
| PBT | -0.01 | 0.12 | 0 | 2.58 | 6.13 | 4.83 | 4.64 |
| Tax % | 0% | 25% | — | 7.75% | 28.06% | 24.64% | 27.37% |
| Net Profit | -0.01 | 0.09 | -0.01 | 2.37 | 4.41 | 3.64 | 3.37 |
| EPS in Rs | -10 | 90 | -0.2 | 47.4 | 3.71 | 2.21 | 2.04 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.5 | 0.5 | 11.9 | 16.49 | 16.49 |
| Reserves | 0.07 | 0.01 | 0 | 2.03 | 3.12 | 37 | 40.37 |
| Borrowings | 0.4 | 0.69 | 2.54 | 2.48 | 0 | 0 | 0 |
| Other Liabilities | 0.3 | 0.42 | 1.6 | 3.25 | 5.94 | 14.79 | 15.81 |
| Total Liabilities | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 68.28 | 72.67 |
| Fixed Assets | 0.45 | 0.06 | 1.39 | 3.01 | 4.74 | 31.48 | 34.12 |
| CWIP | 0 | 0.45 | 1.9 | 0 | 0.86 | 0.61 | 0.43 |
| Investments | 0.24 | 0 | 0 | 2 | 6.51 | 18.58 | 11.82 |
| Other Assets | 0.09 | 0.62 | 1.35 | 3.25 | 8.85 | 17.61 | 26.3 |
| Total Assets | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 68.28 | 72.67 |
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating | — | 0.23 | 0.62 | 4.12 | 0.91 | 7.82 | 2.21 |
| Investing | — | -0.06 | -2.81 | -2.33 | -7.54 | -39.56 | -0.48 |
| Financing | — | 0.28 | 2.32 | -0.08 | 5.6 | 35.1 | 0 |
| Net Cash Flow | — | 0.44 | 0.13 | 1.71 | -1.03 | 3.37 | 1.73 |
| Free Cash Flow | — | 0.16 | -2.28 | 3.62 | -2.38 | -21.98 | -5.59 |
| CFO/OP | — | 133 | 493 | 121 | 50 | 154 | 48 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 20.28 | 0.85 | 2.01 | 25.61 | 24.85 |
| Inventory Days | — | 8.83 | 41.93 | 35.25 | 14.07 | 34.38 | 31.68 |
| Days Payable | — | 94.19 | 113 | 69.03 | 75.17 | 107 | 92.84 |
| Cash Conversion Cycle | 0 | -85.36 | -51.24 | -32.93 | -59.09 | -47.33 | -36.31 |
| Working Capital Days | -169 | -88.24 | -125 | -56.81 | -36.86 | -51.23 | 37.1 |
| ROCE % | — | 25.21% | 1.6% | 65.84% | 60.41% | 11.27% | 8.7% |
Documents
1
Outcome of Board Meeting
7 Aug - Board approved Q1 FY27 results, Tulip Hospital closure, Malda HOMA, Ranchi collaboration, AGM on 25 Sept 2026. 7 Aug - Board approved Q1 FY27 results, Tulip Hospital closure, Malda HOMA, Ranchi collaboration, AGM on 25 Sept 2026.
2
Statement of deviation(s) or variation(s) under Reg. 32
7 Aug - Submitted IPO proceeds utilization statement to 30 June 2026; no deviation reported. 7 Aug - Submitted IPO proceeds utilization statement to 30 June 2026; no deviation reported.
3
Outcome of Board Meeting
7 Aug - Board approved Q1 FY27 results; Tulip Hospital Ranchi discontinued; NSE non-compliance notice noted; AGM on 25 Sept 2026. 7 Aug - Board approved Q1 FY27 results; Tulip Hospital Ranchi discontinued; NSE non-compliance notice noted; AGM on 25 Sept 2026.
4
Structural Digital Database
16 Jul - Filed SDD compliance certificate for quarter ended 30 June 2026; no non-compliance observed. 16 Jul - Filed SDD compliance certificate for quarter ended 30 June 2026; no non-compliance observed.
5
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
10 Jul - Company states corporate governance provisions are not applicable for quarter ended 30 June 2026. 10 Jul - Company states corporate governance provisions are not applicable for quarter ended 30 June 2026.
Frequently Asked Questions about Nephro Care India Ltd
What does Nephro Care India Ltd do?
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes
in the treatment of kidney- related diseases[1]
Where is Nephro Care India Ltd (NEPHROCARE) listed?
Nephro Care India Ltd is listed on the Indian stock exchanges. It is listed on NSE: NEPHROCARE. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Nephro Care India Ltd belong to?
Nephro Care India Ltd operates in the Healthcare Services sector within the Hospitals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Nephro Care India Ltd?
Nephro Care India Ltd has a market capitalisation of approximately ₹151.67 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Nephro Care India Ltd?
The Price-to-Earnings (PE) ratio of Nephro Care India Ltd is 44.80. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Nephro Care India Ltd?
Over the past 52 weeks, Nephro Care India Ltd has traded between a low of ₹50.05 and a high of ₹183. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Nephro Care India Ltd?
Nephro Care India Ltd has a Return on Equity (ROE) of 6.80%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Nephro Care India Ltd on Tapetide?
On Tapetide, you can view Nephro Care India Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney- related diseases[1]